newsfilter
← Latest News
GlobeNewswire·

Zentalis Pharmaceuticals Announces Proposed Underwritten Public Offering

SAN DIEGO, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (NASDAQ:ZNTL) ("Zentalis" or the "Company"), a clinical oncology innovator advancing late-stage development of an